Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Hemophilia B

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Hemophilia B:

Pubmed Logo
Proteasome Inhibitors Decrease AAV2 Capsid derived Peptide Epitope Presentation on MHC Class I Following Transduction.
Adeno-associated viral (AAV) vectors are an extensively studied and highly...
12th November, 2009
Department of Pediatrics, Division of Hematology, The Children's Hospital Mol Ther. 2009 Nov 10.
DOI Direct Link
Genotype analysis identifies the cause of the "royal disease".
The "royal disease," a blood disorder transmitted from Queen Victoria to...
10th October, 2009
University of Massachusetts Medical School, 303 Belmont Street, Worcester, Science. 2009 Nov 6;326(5954):817. Epub 2009 Oct 8.
DOI Direct Link
The Jeremiah Metzger Lecture: gene therapy for inherited disorders: from Christmas disease to Leber's amaurosis.
This paper will focus on recent developments in the field of gene therapy...
22nd September, 2009
3615 Civic Center Boulevard, 302D Abramson Pediatric Research Center, Trans Am Clin Climatol Assoc. 2009;120:331-59.
Therapeutic properties and safety of recombinant factor VIII and factor IX.
Advances in hemophilia management in the 20th century enabled effective...
18th September, 2009
Department of Hematology, Jagiellonian University School of Medicine, Pol Arch Med Wewn. 2009 Jun;119(6):403-9.
Novel human pathological mutations. Gene symbol: F9. Disease: Haemophilia B.
Advances in hemophilia management in the 20th century enabled effective...
9th September, 2009
Medical Genetics, Centre of Excellence in Molecular Biology, Lahore, Hum Genet. 2009 Aug;126(2):332.

View more research publications.

Press Releases About Hemophilia B:

BioPortfolio Logo
AMT Provides Business Update for the Third Quarter 2009 18th November, 2009
AMSTERDAM, November 18 /PRNewswire/ -- Amsterdam Molecular Therapeutics (EuroNext Amsterdam: AMT), a leader in the field of human gene therapy, today provides its non-audited business update in
These Patients Need Your Help This Thanksgiving 17th November, 2009 New York Blood Center
NEW YORK, Nov. 17 /PRNewswire-USNewswire/ -- As we approach Thanksgiving, "Black Friday" and the holiday season, New York Blood Center (NYBC) calls upon the community to please remember the
Diplomat Specialty Pharmacy Continues to Expand - Opens Location in Southern California 17th November, 2009 Diplomat Specialty Pharmacy
SWARTZ CREEK, Mich., Nov. 17 /PRNewswire/ -- Diplomat Specialty Pharmacy announced today the opening of their branch in San Bernardino, CA. Diplomat has 6 additional locations in Michigan, Ohio,
World Champion New York Yankees, BNY Mellon to be Honored as New York Blood Center 'Champions of Life' 15th November, 2009 New York Blood Center
NEW YORK, Nov. 15 /PRNewswire/ -- The World Champion New York Yankees and BNY Mellon will be honored as "Champions of Life" at New York Blood Center's (NYBC) Biennial Chairman's
Community Blood Drives Benefit Cancer Patients 30th October, 2009 New York Blood Center
NEW YORK, Oct. 30 /PRNewswire-USNewswire/ -- November is both Pancreatic Cancer Awareness Month and Lung Cancer Awareness Month, and New York Blood Center (NYBC) and its divisions in Manhattan, Long

BioNews Results for Hemophilia B:

RSS Logo
BioPortfolio Logo
Clinical Exposures: Hemophilia A in a Maltese dog
Thomson Veterinary Healthcare Communications:  Nov 11 2009 6:03AM Matching: hemophilia b
BAC signs licensing agreement with Octapharma
Therapeutics Daily:  Nov 6 2009 12:20PM Matching: hemophilia b
PTC Therapeutics Initiates Phase 2 Clinical Trial of ataluren (PTC124(R)) in Patients with Hemophilia
PR Newswire:  Oct 28 2009 12:33PM Matching: hemophilia b
PTC Therapeutics Initiates Phase 2 Clinical Trial of ataluren (PTC124(R)) in Patients with Hemophilia
Genetic Engineering News:  Oct 28 2009 9:34AM Matching: hemophilia b
PTC Therapeutics Initiates Phase 2 Clinical Trial Of Ataluren (PTC124(R)) In Patients With Hemophilia
Medical News Today:  Oct 27 2009 8:52AM Matching: hemophilia b
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Hemophilia B Clinical Trials:

Clinical Trials Logo
Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B

Hemophilia B Patents:

USPTO Logo
US Patent No.Title
7491537 Nucleic acid formulations for gene delivery and methods of use
7517974 Factor VII or VIIa-like molecules
7524501 Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies
7524931 Full-length interferon gamma polypeptide variants
7531353 Non self-inactivating, expression targeted retroviral vectors

View more patents.

Companies working in the area of Hemophilia B from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Syntonix Pharmaceuticals, Inc.

Syntonix is developing next generation biopharmaceuticals that enable better treatment options for patients with devastating chronic diseases such as hemophilia, anemia, multiple sclerosis, and...
www.syntnx.com/        View full profile
Thumbshot

BioPortfolio Ltd. offers e-mail and postal lists for Hemophilia B scientists - we have details of around 298 individuals working on Hemophilia B .


This page has been viewed 445 times
Recent Search Terms used to find this page: Special Lectures in Hemophilia Management pdf | haemophilia B in pdf format | 2009 Hemophiliac Caps in Pennsylvania | hemofilia B | hemophilia B patient resources pdf | hemofilia b pdf | haemophilia -- latest news 2009 | hemophilia | haemophilia trials 2009 | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Hemophilia B across BioPortfolio, or for Hemophilia B Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.